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Objective. To evaluate a 12-week group-based lifestyle intervention programme for women with prediabetes following gestational
diabetes (GDM). Design. A two-group, mixed methods randomized controlled trial in which 50 women with a history of GDM
and abnormal glucose tolerance postpartum were randomly assigned to intervention (𝑛 = 24) or wait control (𝑛 = 26)
and postintervention qualitative interviews with participants. Main Outcome Measures. Modifiable biochemical, anthropometric,
behavioural, and psychosocial risk factors associated with the development of type 2 diabetes. The primary outcome variable was
the change in fasting plasma glucose (FPG) from study entry to one-year follow-up. Results. At one-year follow-up, the intervention
group showed significant improvements over the wait control group on stress, diet self-efficacy, and quality of life. There was no
evidence of an effect of the intervention on measures of biochemistry or anthropometry; the effect on one health behaviour, diet
adherence, was close to significance. Conclusions. Prevention programmes must tackle the barriers to participation faced by this
population; home-based interventions should be investigated. Strategies for promoting long-term health self-management need to
be developed and tested.
1. Introduction
Women with a history of gestational diabetes (GDM) are
at increased risk of developing type 2 diabetes compared to
those with normoglycaemic pregnancies [1]. Studies inves-
tigating glucose function in the early postnatal period have
shown the prevalence of type 2 diabetes to be as high as 38%
in the first year postpartum [2] and as high as 60% in women
followed for up to 16 years postpartum [3]. The postpartum
period is a very important time in determining the future risk
of type 2 diabetes in women with GDM; thus there is a strong
rationale for preventive interventions at this time.
Some risk factors associatedwith the development of type
2 diabetes are nonmodifiable such as such as age, ethnicity,
or a family history of diabetes. However, some risk factors
such as weight, elevated blood glucose, and triglycerides
are potentially modifiable though diet, exercise, and lifestyle
change [4]; for example, modest weight loss has been shown
to be effective in reducing the risk of developing type 2
diabetes in at-risk populations [5].
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Large scale randomised controlled trials (RCTs) have
shown that the onset of type 2 diabetes can be prevented or
delayed by lifestyle intervention in high-risk cohorts [6–8].
However, these studies include mixed gender (usually older)
adults. A subgroup analysis of post-GDM women from the
Diabetes Prevention Programme showed a 50% reduction in
diabetes incidence with lifestyle intervention versus placebo
inwomen at amean of 12 years following theGDMpregnancy
[9]. Evidence to support the efficacy of lifestyle intervention
in women with a recenthistory of GDM is however lacking.
A limitation of the above literature is the lack of attention
to psychosocial risk factors in lifestyle interventions to
prevent diabetes. Factors such as mood, self-efficacy beliefs,
and social support have been shown to be associated with
prediabetes and type 2 diabetes [10], diabetes related self-
care [11], and willingness to engage in lifestyle change [12].
Moreover lifestyle intervention has been associated with
positive changes in mood and health outcomes in mixed
gender groups with diabetes risk factors [13, 14]. There is a
need to investigate the long term sustainability of such effects,
particularly in women with previous GDM.
Thus research is required which investigates (i) the ef-
ficacy of lifestyle intervention in improving the risk factors
associated with the development of type 2 diabetes in women
with a recent history of GDM, (ii) the role of psychosocial
factors in facilitating behavior change, and (iii) the long
term sustainability of behavioural improvements. This study
sought to answer these questions through mixed methods
RCT to evaluate the effectiveness of an intensive 12-week
group based lifestyle intervention programme, MyAction
[15], as compared with standard care, in reducing diabetes
risk factors in women 1–3 years after GDM. The MyAc-
tion programme uses a combination of education, exercise
classes, and cognitive-behavioural approaches to empower
individuals and families tomake sustainable lifestyle changes.
The programme has been shown to be effective in reducing
cardiovascular risk factors [16]; but it has not been assessed
in women with prior GDM.
In this study, therefore, the effectiveness of theMyAction
programme was measured in terms of a reduction in the
modifiable biochemical, anthropometric, behavioural, and
psychosocial risk factors associated with the development of
type 2 diabetes in women with prior GDM and persistent
glucose abnormality postpartum. Postintervention qualita-
tive interviews with participants will provide context to the
findings.
2. Materials and Methods
Ethical approval for the study was obtained in March 2012
from the Clinical Research Ethics Committee of Galway
UniversityHospital, part of Ireland’sHealth Service Executive
(HSE).
2.1. Participants. Potential participants were identified from
the Atlantic Diabetes in Pregnancy (DIP) research database
and the pregnancy service of Galway University Hospital
Group.Women with a recent history of GDM (i.e., diagnosed
GDM in the past 1–3 years) by International Association
of Diabetes and Pregnancy Study Group (IADPSG) diag-
nostic criteria [17] were contacted by letters and follow-up
phone calls. The recruitment and randomisation process is
described in detail in the trial protocol [18].
Inclusion criteria were at least one of the following
at study entry: (1) impaired fasting glucose (IFG) (fasting
plasma glucose levels of 5.6−6.9mmol/L); (2) impaired
glucose tolerance (IGT) (two-hour plasma glucose levels
of 7.8−11.0mmol/L); (3) insulin resistance (IR) based on
homeostasis model assessment (HOMA2-IR ≥ 1.7) plus at
least two of the following risk factors: (a) blood pressure >
130/80mmHg, (b) total cholesterol > 4.5mmol/L, (c) LDL
cholesterol >2.5mmol/L, (d) triglycerides >1.69mmol/L, (e)
HDL cholesterol <1.29mmol/L, (f) obesity (defined as BMI
>30 kg/m2), and (g) waist circumference >88 cm. Exclusion
criteria were (i) type 2 diabetes; (ii) current pregnancy;
(iii) insufficient English language fluency to understand the
programme content. The recruitment process spanned 10
months, from June 2012 to March 2013.
2.2. Description of Intervention/ComparisonGroup. Thestudy
design was a two-group, parallel RCT. Following baseline
assessments, eligible participants were randomly assigned to
the intervention or wait control group in an equal ratio of 1 : 1.
An independent researcher was responsible for generating
the allocation sequence and for assigning participants to the
intervention groups. Those assigned to the intervention
group received the 12-week intensive lifestyle programme,
MyAction. Full background to the MyAction programme is
provided in the trial protocol [18]. Briefly, the programme
is delivered by a multidisciplinary team of nurses, dieti-
cians, and physical activity specialists and is supported by a
physician. The programme includes an initial individualised
assessment followed by 12 weekly sessions of 2.5 hours each
week comprising of a one-hour group exercise programme, a
group education seminar, and a one-to-one session involving
a motivational interview and individual goal setting with a
specialist nurse, physiotherapist, or dietician. The wait con-
trol group receives the standard health care advice provided
to women with previous GDM. In this study, standard care
is defined as (i) educational pamphlets for reducing diabetes
risks and (ii) routine follow-up by the participant’s own
general practitioner.
2.3. Outcomes. The primary outcome measure is the mean
change in FPG levels from the time of the baseline assessment
to the one-year follow-up assessment. Secondary outcomes
were mean change in 2-hour postload glucose tolerance
(GT2h), insulin resistance (IR), diet adherence, weight and
waist circumference, physical activity, fitness and lipid profile
and measures of mood, cognition, and wellbeing. Partici-
pants in the intervention cohort also underwent evaluation
for some secondary outcomes immediately following the
intervention. Table 1 outlines the definitions, measurement
techniques, and time points for each of the outcomes.
2.4. Sample Size and Power Calculation. The sample size
required for the RCT was 54 participants. This number
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Table 1: Primary and secondary outcome measures and measurement time points.






Reduction in FPG (0-hour) on a 75 gram oral glucose




Reduction in postload glucose tolerance (2-hour) on a 75
gram OGTT ✓ ✓
Insulin resistance (IR)
Reduction in IR as measured by Homeostasis Model
Assessment (HOMA2- IR), using fasting glucose and insulin
values [33] on a 75 gram OGTT
✓ ✓
Lipid profile (i) Reduction in triglycerides, LDL, and total cholesterol(ii) Improvement in HDL cholesterol ✓ ✓ ✓
Diet adherence
Improvement in overall Mediterranean Diet Score, a
composite diet index based on the traditional Mediterranean
dietary pattern [34]
✓ ✓ ✓
Weight and shape (i) Reduction in weight (kilograms)(ii) Reduction in waist circumference (CM) ✓ ✓ ✓
Physical activity and
fitness
(i) Total exercise per week (frequency × duration)
(ii) Change in cardiorespiratory fitness measured using
maximal metabolic equivalent (METmax) on an objective
physical fitness test (Chester Step Test) [35]
✓ ✓ ✓
Mood
(i) Positive mental health: 4 items from RAND SF-36
questionnaire addressing affective aspects of wellbeing [21]
(ii) Nonspecific psychological distress: 5 items from the
Mental Health Index-5 (MHI-5) in the RAND SF-36
questionnaire [21]
(iii) Depression, anxiety, and stress: 21 items from
Depression, Anxiety, and Stress Scale (DASS-21) [22]
✓ ✓
Cognition
(i) Perceived social support: Multidimensional Scale of
Perceived Social Support from family, friends, and a
significant other [25]
(ii) Motivation to change: a one item forced choice question
with 5 options to assess current stage of change [13]
(iii) Diabetes-related self-efficacy: 18-item assessment of
confidence to engage in exercise and healthy eating under
different “barrier” conditions [13]
✓ ✓
Wellbeing
(i) General health: stand-alone measure of self-rated health
included in the Irish Survey of Lifestyle, Attitudes, and
Nutrition (SLÁN), 2007 [23]
(ii) Quality of life: single-item assessment included in SLÁN
2007 [23]
✓ ✓
was calculated based on estimates provided from pilot data
from women with a history of GDM (𝑛 = 74) receiving
conventional health care. The pilot group had a standard
deviation of 0.64mmol/L for the difference in FPG on an
OGTTbetween two time points: approximately threemonths
postpregnancy and then one to three years later. Given the
standard deviation, it was estimated that a sample size of 27 in
each study arm was necessary to have 80% power (at the 0.05
significance level) to detect a mean difference of 0.5mmol/L
in FPG between baseline and one-year follow-up in the two
study arms.
2.5. Statistical Analysis. Suitable numerical (mean and stan-
dard deviation) and graphical summaries (box and scatter-
plots) were used to compare the groups at baseline and to
provide interval estimates of the mean difference at end of
programme assessment (EOP) (on a subset of variables) and
at one-year follow-up on all measured variables. A linear
model (ANCOVA) was used to investigate the effect of
intervention on the change in glucose function at follow-up,
while adjusting for baseline as a covariate and for patient
characteristics; subsequently, ridge regression was used to
adjust for multicollinearity between covariates. All analyses
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were performed as intention to treat analysis. All analyses
were carried out using the software packages R (version 3.0)
and Minitab 16 Statistical Software. All model assumptions
were assessed using suitable residual plots.
2.6. Qualitative Methods and Analysis. Semistructured inter-
views were conducted with 17 trial participants who were
randomized to the intervention group.Of those, 12 completed
the intervention and 5 were noncompleters. An interview
guide with open ended questions was used to elicit respon-
dents experiences of the intervention, barriers, and facilita-
tors to lifestyle change, social support, efficacy beliefs, and
beliefs about optimal interventions for this population. All
of the interviews were conducted face-to-face at the time
of the one-year follow-up assessment. All interviews were
digitally recorded with the permission of each participant
and were transcribed verbatim. Interview transcripts were
analysed thematically using an inductive approach [19]. The
transcripts were read and reread and noteworthy aspects of
the data were systematically coded. Then the coded text was
organised into broad themes. Following this, the themes were
reviewed, refined, and named.
3. Results
Out of 410 women who received information about the trial,
89 agreed to participate and were assessed for eligibility. Of
these, 50 met eligibility criteria for inclusion into the trial.
Of the 50 eligible participants, 26 were randomised to the
MyAction lifestyle intervention programme and 24 to thewait
control group, who received standard care.
3.1. Attendance Rates. Of the 24 participants randomized
to the intervention group, 14 (58%) were deemed to have
completed the interventionwith attendance rates≥6 sessions.
The average number of sessions attended by the completers
was 9.5. The remaining 10 participants (42%) either did not
start the intervention (𝑛 = 4), had attendance rates <6
sessions (𝑛 = 4), or deferred due to pregnancy (𝑛 =
2). Of the intervention completers (𝑛 = 14), 13 attended
EOP assessment which took place immediately following
completion of the programme, and all 14 completers attended
the one-year follow-up assessment which took place one year
following programme commencement. Two noncompleters
also attended one-year follow-up assessment and are included
in the ITT analysis. Loss to follow-up was 33% for the
intervention group and 23% for the control group. The flow
diagram in Figure 1 represents the movement of participants
through the stages of the study.
3.2. Baseline Analysis. A comparison of control and interven-
tion groups at baseline (see Table 2) revealed that groupswere
comparable on all measured variables except GT2h, which
was significantly higher for the control than for the interven-
tion group (𝑝 = 0.025). The boxplot in Figure 2 shows indi-
vidual values on GT2h in both groups. Thus randomisation
was not successful in ensuring that groups were comparable
on baseline glucose tolerance. Participants in both groups
are within the normal ranges on lipid profile; however their
weight is high and, resultantly, BMI and waist circumference
are well above the recommended range. Exercise per week is
below the recommended range of 150 minutes of moderate
intensity exercise per week. Participants in both groups
scored approximately 6 out of a possible 14 for baseline adher-
ence to the recommended diet. In terms of fitness participants
in both groups have aMETmax score of approximately 8; this
is slightly below the desirable level of 9 which is associated
with lowest risk [20]. On the psychosocial variables, partic-
ipants in this study scored less favorably than population
norms on energy and vitality (EVI) and on psychological
distress [21], but within the normal range on depression
anxiety and stress [22]. On general health and quality of life
participants scored in the middle of the range, indicating
median levels of satisfaction on these variables [23]. Mean
levels of social support from family, friends, and a significant
otherwere comparable to previously reported studies [24, 25].
In terms of motivation to change, respondents score in the
middle range on a 5-point scale which represents an intention
to change but no initiation of change behaviour. Scores on
exercise and diet self-efficacy fall in the middle range and are
comparable to those reported elsewhere [13].
3.3. Analysis of Improvement from Baseline to End of Pro-
gramme (EOP). The intervention groupwas tested at EOP on
a subset of variables. Analysis of improvement from baseline
to EOP revealed significant improvement in weight, BMI,
waist circumference, fitness (METmax), total cholesterol, and
LDL cholesterol. There was a significant disimprovement in
mean HDL cholesterol (𝑝 = 0.02) and no significant change
in mean triglycerides (𝑝 = 0.54). Table 3 shows improvement
from baseline to EOP for (𝑛 = 13) participants who
completed the intervention and returned for EOP follow-up
testing. In each case, positive scores represent improvement,
and negative scores represent disimprovement.
3.4. Analysis of Improvement from Baseline to
One-Year Follow-Up
3.4.1. Biochemistry. Paired 𝑡-tests using nonadjusted scores
revealed no evidence of a significant intervention effect on the
primary outcome, FPG values (𝑝 = 0.36), or on IR (𝑝 = 0.94);
however, there was evidence of a significant improvement
in the intervention group on GT2h (𝑝 = 0.02). There were
no significant differences between groups on lipid profile.
Linear regression models (ANCOVA), adjusting for baseline
and other participant characteristics (BMI, cholesterol, and
fitness), were used to estimate the effect of the intervention
on FPG, GT2h and IR. A significant intervention effect was
found for GT2h (𝑝 = 0.03), but not for FPG (𝑝 = 0.67)
or insulin resistance (𝑝 = 0.33). However, when a ridge
regression penalty was introduced in order to adjust for
multicollinearity between covariates, no significant effect of
the intervention was found on FPG (𝑝 = 0.44), GT2h (𝑝 =
0.16), or IR (𝑝 = 0.27).There was, however, an effect of fitness
at baseline on GT2h with higher levels of fitness (METmax)
being associated with greater improvement (𝑝 = 0.01).
Journal of Diabetes Research 5
1-year follow-up







End of programme assessment
Assessed for eligibility (n = 89)
(i) Not meeting inclusion criteria (n = 36)
(ii) Type 2 diabetes (n = 3)
Excluded (n = 39)
Randomised (n = 50)
Allocated to intervention (n = 24)
(i) Received allocated intervention (n = 14)
(ii) Did not receive allocated intervention (n = 10)
Allocated to usual care (n = 26)
Received allocated intervention (n = 26)
Analysed (n = 13,54%)
Analysed (n = 16,66%) Analysed (n = 20,76%)
Lost to follow-up (n = 8,33%) Lost to follow-up (n = 6,23%)
Unable or unwilling to return for1-year
follow-up assessment
(a) Deferred (pregnant) (n = 2)
(b) Did not start (n = 4)
(c) Attended < 6 sessions (n = 4)




























Boxplot of baseline postload glucose (2 hours)
Figure 2: Boxplot of baseline glucose tolerance (2-hour) (GT2h) per
group.
3.4.2. Anthropometry. There were no significant differences
in improvement between groups on weight, BMI, or waist
circumference. An ANCOVA model revealed no significant
intervention effect on BMI after adjusting for baseline BMI
and other participant characteristics: mood, cognition, well-
being, diet adherence, and fitness levels (𝑝 = 0.57). When
ridge regression penalty was introduced in order to adjust
for multicollinearity between covariates, no significant effect
of the intervention was found for BMI (𝑝 = 0.91); however
there was a significant negative effect of depression at baseline
on improvement in BMI (𝑝 = 0.05), with higher depression
being associated with lower levels of improvement.
3.4.3. Behaviour. There were no significant differences
between groups on diet adherence or physical activity.
ANCOVA models revealed no significant intervention effect
on diet adherence (𝑝 = 0.53) or physical activity levels
(𝑝 = 0.33) after adjusting for baseline mood, cognition, and
wellbeing. However, ridge regression analysis revealed that
the effect of the intervention on diet adherence was nearing
significance (𝑝 = 0.07); the effect of family support on this
outcome was also nearing significance (𝑝 = 0.06). There
was no significant effect of intervention on physical activity
6 Journal of Diabetes Research











Fasting plasma glucose 5.36 (0.59) 5.37 (0.54) 0.95 −0.33, 0.31
Glucose tolerance (2 hours)† 5.60 (1.65) 6.69 (1.66) 0.02 −2.03, −0.14
Insulin resistance (HOMA) 3.02 (1.19) 2.62 (1.19) 0.25 −0.30, 1.09
Lipids profile
Triglycerides 1.59 (0.69) 1.26 (0.65) 0.08 −0.05, 0.71
HDL cholesterol 1.34 (0.37) 1.39 (0.35) 0.60 −0.26, 0.15
LDL cholesterol 3.17 (0.89) 2.96 (0.79) 0.38 −0.27, 0.69
Total cholesterol 5.24 (1.03) 4.95 (0.76) 0.26 −0.22, 0.80
Weight and shape
Weight 97.99 (19.91) 93.25 (16.62) 0.36 −5.66, 15.15
BMI 35.53 (6.86) 35.49 (6.25) 0.98 −3.70, 3.77
Waist circumference 115.42 (19.12) 112.0 (14.07) 0.48 −6.61, 12.6
Physical activity and diet
Total PA per week 82.7 (103.1) 66.7 (96.9) 0.54 40.9, 72.9
Estimated METmax 8.59 (1.75) 7.97 (1.57) 0.19 −0.33, 1.57
Mediterranean diet score 6.08 (2.33) 6.62 (2.34) 0.41 −1.87, 0.78
Mood
Energy and vitality (EVI) 44.81 (22.34) 48.54 (19.42) 0.53 −15.68, 8.21
Negative PD (NPD) 67.23 (16.16) 66.00 (17.97) 0.80 −8.47, 10.93
Depression 5.31 (5.48) 4.67 (4.13) 0.72 −2.29, 3.26
Anxiety 3.81 (4.06) 3.67 (3.42) 0.83 −1.93, 2.36
Stress 6.96 (5.18) 6.63 (4.92) 0.85 −2.59, 3.11
Cognition
Motivation to change (MTC) 3.53 (0.86) 3.25 (0.94) 0.26 −0.22, 0.80
Social support: significant other 6.43 (2.88) 5.72 (7.18) 0.06 −0.21, 5.92
Social support: family 5.28 (7.59) 5.12 (6.06) 0.75 −3.31, 4.54
Social support: friends 5.43 (4.42) 5.12 (6.16) 0.41 −1.80, 4.30
Exercise self-efficacy 3.39 (0.93) 3.14 (0.89) 0.21 −0.19, 0.83
Diet self-efficacy 3.38 (0.85) 3.01 (0.77) 0.19 −0.16, 0.78
Wellbeing
General health (GH) 2.92 (0.89) 2.95 (0.95) 0.38 −0.23, 0.59
Quality of life (QOL) 3.81 (0.56) 3.62 (0.87) 0.89 −0.56, 0.48
†
𝑝 < 0.05.
levels (𝑝 = 0.38), nor was there an effect of baseline mood,
cognition, or wellbeing on this outcome.
3.4.4. Psychosocial. On the psychosocial variables, significant
differences between groups were observed on stress, diet
self-efficacy, and quality of life with the intervention group
improving significantly over the control group. Table 4 dis-
plays the 𝑝 values and confidence intervals for analysis of dif-
ferences. In each case, positive scores represent improvement
and negative scores represent disimprovement.
3.5. Qualitative Results. Below the attitudes and opinions
of intervention group “completers” and “noncompleters” are
presented.
3.5.1. Reasons for Dropping out and Nonattendance
Child Care Responsibilities. For the women who did not
complete the intervention and for several women who did
complete it, childcare responsibilities were cited as the main
barrier to attendance. Some women had no one to leave
Journal of Diabetes Research 7
Table 3: Improvement from baseline to EOP (intervention group only).





95% confidence interval for
mean improvement
Weight (kg)‡ 90.71 (13.30) 88.09 (13.98) 2.62 (2.87) 0.006 (0.88, 4.36)
BMI† 34.98 (4.52) 33.93 (4.57) 1.04 (1.55) 0.03 (0.10, 1.98)
Waist circumference (cm)† 112.3 (14.69) 107.63 (18.13) 4.68 (5.11) 0.016 (1.25, 8.11)
Med diet score∗ 6.92 (2.29) 7.84 (3.21) 0.92 (2.53) 0.21 (−2.45, 0.60)
Estimated METmax∗‡ 8.17 (1.36) 9.59 (1.58) 1.42 (0.87) 0.001 (0.86, 1.97)
Total cholesterol† 5.08 (0.68) 4.40 (0.46) 0.68 (0.80) 0.013 (0.13, 1.22)
Triglycerides 1.23 (0.59) 1.32 (0.68) −0.09 (0.48) 0.54 (−0.41, 0.23)
HDL cholesterol∗† 1.41 (0.35) 1.21 (0.28) −0.20 (0.25) 0.02 (−0.36, −0.03)
LDL cholesterol† 3.07 (0.70) 2.60 (0.43) 0.47 (0.60) 0.03 (0.03, 0.90)
†
𝑝 < 0.05, ‡𝑝 < 0.01.
∗On these variables higher scores at EOP represent an improvement in function.Thus improvement is calculated by subtracting baseline score from EOP score.
On all other variables a lower score at EOP represents improvement; therefore, improvement is calculated by subtracting EOP score from baseline score.
their children to, and others did not want to leave their
children. Approximately 50% of the women in the study
worked outside of the home; many of them expressed feeling
guilty about leaving the children for a full evening each week.
It’s just not an option for me; I do not have anyone
to leave the children to.
I feel I need to be at home to do the homeworkwith
the children and put them to bed.
I could not come home from a long shift at work
and pick her up from her childcare and go out
again straight away.
Time and Travel. For the women who did not complete the
intervention, lack of time was cited as the main reason for
dropping out. In addition several women stated that they
could not commit to a regularly scheduled time or that
the program took too much time. For women from rural
locations, the travel time was also a barrier to attendance.
The main reason I gave up coming was time, it
took up my whole night.
Could not make the regularly scheduled times.
I tried to fit it into my schedule but the drive was
really too far.
Not Prioritising Oneself. Many of the participants expressed
difficulties in prioritizing themselves and their health over the
needs of their families. In many cases the educational, social,
and exercise needs of their children and their partners took
precedence over their own health needs.
You cannot both leave the house.
I feed my children healthy food but I do not take
care of myself.
3.5.2. Facilitators to Attendance
Support fromPartner. Support froma significant other, specif-
ically the life partner or husband, was critically important for
the women in this study. None of the women who did not
have a partner were able to complete the program. For those
who completed, the support of their partner was crucial to
their ability to take time away from the family. The women
in this study preferred not to ask extended family members
to support in childcare in order for them to participate in the
intervention.
I couldn’t have done it if my husband hadn’t been
supportive of it.
My children are my responsibility, I do not ask
other people to mind them unless it’s an emer-
gency.
3.5.3. Motivation to Change
Weight Loss. For all of the women, the main motivation
cited for participation in the program was to lose weight.
Improving diabetes risk factors and general health concerns
were a secondary motivation.
My problem always needs to get solved; I always
need to lose weight.
Accountability. The weekly one-to-one interview and the
“weigh-in” emerged as the key motivators for participants.
Accountability to the health care teamwas a strongmotivator
to adhere to health goals.
I knew that I would be getting weighed-in each
week and having to be accountable to the staff.
The program was the motivation.
3.5.4. Programme Benefits
Stress, Mood, and Wellbeing. Participants that completed the
intervention reported improvements in their mood and self-
confidence as a result of the program. Improved confidence
8 Journal of Diabetes Research






intervention (𝑛 = 16)
mean (sd)
𝑝 value 95% CI for difference inmean improvement
Glucose function
Fasting plasma glucose (0 h) −0.13 (0.63) 0.04 (0.45) 0.36 (−0.54, 0.20)
Glucose tolerance (2 h)† −0.27 (1.46) 0.81 (1.21) 0.02 (−1.99, −0.18)
Insulin resistance 0.41 (1.21) 0.45 (1.63) 0.94 (−1.15, 1.07)
Lipids profile
Triglycerides 0.09 (0.47) −0.14 (0.76) 0.31 (−0.23, 0.68)
HDL cholesterol∗ 0.02 (0.28) −0.11 (0.20) 0.13 (−0.04, 0.29)
LDL cholesterol 0.33 (0.64) 0.34 (0.59) 0.96 (−0.43, 0.41)
Total cholesterol 0.23 (0.44) 0.39 (0.84) 0.50 (−0.65, 0.33)
Weight and waist circumference
Weight (kg) 0.08 (5.66) 0.84 (4.93) 0.67 (−4.36, 2.83)
BMI −0.10 (2.19) 0.19 (1.83) 0.67 (−1.65, 1.08)
Waist circumference (cm) −0.01 (9.18) 0.81 (7.24) 0.77 (−6.48, 4.83)
Physical activity and diet
Total physical activity per week (mins)∗ 52.0 (103) −9.2 (93) 0.10 (−12.6, 134.6)
Estimated METmax∗ 0.13 (1.46) 0.99 (1.68) 0.13 (−0.27, 1.99)
Mediterranean diet score∗ 0.62 (2.22) 0.00 (2.06) 0.39 (−.82, 2.06)
Mood
Energy and vitality −3.36 (18.25) 1.56 (5.21) 0.37 (−15.68, 8.21)
Nonspecific psychological distress 3.24 (15.37) 8.00 (15.93) 0.51 (−8.47, 10.93)
Depression 1.90 (3.42) 3.43 (3.81) 0.21 (−2.29, 3.27)
Anxiety 0.90 (2.88) 1.31 (2.38) 0.64 (−1.93, 2.37)
Stress† 0.95 (2.11) 3.31 (3.94) 0.04 (−4.62, −0.11)
Cognition
Motivation to change∗ 0.33 (1.19) 0.75 (1.43) 0.35 (−0.22, 0.80)
Social support: significant other∗ 0.09 (3.98) 2.50 (7.00) 0.23 (−0.21, 5.92)
Social support: family∗ 0.43 (4.26) 1.62 (3.61) 0.27 (−3.31, 4.54)
Social support: friends∗ 0.38 (4.18) 2.07 (4.54) 0.38 (−1.80, 4.31)
Exercise self-efficacy∗ −0.21 (1.19) 0.02 (0.91) 0.33 (−0.19, 0.83)
Diet self-efficacy∗† −0.52 (1.06) 0.08 (0.72) 0.04 (−1.19, −0.008)
Wellbeing
General health∗ −0.04 (0.59) 0.31 (0.94) 0.19 (−0.56, 0.49)
Quality of life∗† −0.09 (0.83) 0.46 (0.64) 0.02 (−1.061, −0.063)
†
𝑝 < 0.05.
∗On these variables higher scores at 1-year follow-up represent an improvement in function.Thus, improvement is calculated by subtracting baseline score from
1-year follow-up score. On all other variables a lower score at 1-year follow-up represents improvement; therefore, improvement is calculated by subtracting
1-year follow-up score from baseline score.
is particularly reported in two areas (i) the confidence to
exercise vigorously and (ii) the confidence to prioritise their
own needs along with the needs of their family. It seems that
taking the time to attend the program empowered thewomen
to take time away from the family for their social and health
needs. For many respondents this is something they had not
done since the birth of their children.
It helped me to be more positive about taking care
of myself and it gave me some positive techniques
about fitting in exercise.
It gave me the confidence to leave for the whole
evening.
It has kept my spirits up; from a morale point of
view I won’t underestimate it.
It really has helped me get over a lot of stresses.
Exercise Habit. For somewomenwho completed the program
the benefits of the program appear to be sustained beyond
the duration of the intervention. For these women regular
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exercise has become a daily habit, and they are feeling the
benefits both physically and psychologically. A number of the
women started running on a regular basis, something many
of them had previously not considered as an option.
I am getting out a lot more, I was doing nothing
beforehand.
The biggest benefit I got from the program is the
confidence that I can run.
It spurred me on to running; I find that I love
running.
3.5.5. Limitations of the Programme
Lack of Ownership or Self-Management. For some partic-
ipants, even those that were successful in losing weight
throughout the duration of the study, maintaining improve-
ments to diet and exercise after the programme ended was
a challenge. Many women could not sustain the lifestyle
changes without the support of the intervention.
When it finished I just went back to square one
really.
Without someone to check on you and coax you
and motivate you, the motivation goes.
I found it hard to keep it up after the program.
I stopped exercising once program stopped.
I did well, I lost a good bit of weight but I have it
all on again.
3.5.6. Optimal Lifestyle Intervention. When asked their opin-
ions about and “ideal” lifestyle intervention program all
of the women stated that the program must be accessible
and flexible. Many women stated that online or web based
programmes would work well for them as they could engage
in the program at times that suited them. However they also
valued one-on-one consultations with healthcare profession-
als in order to engage in joint goal setting and performance
monitoring.
I think an online program would work for me.
Something that is flexible, that I could do when-
ever I liked.
4. Discussion
This study is the first to assess the efficacy of a group-based
intervention specifically in women with a recent history of
GDM. Before discussing the findings of the trial two impor-
tant limitations should be noted. First, this trial included
relatively low number of participants due to recruitment and
retention challenges with this population [26]. Although we
almost reached our sample target of 54 participants, 42% of
those randomized to the intervention group did not complete
the intervention. Thus, assessing the true efficacy of this
intervention is impeded. Second, randomisation was not
successful in ensuring that groups were equivalent in terms of
glucose dysfunction at baseline; here the intervention group
hadhighermeanGT2h than controls; adjustmentsweremade
for this difference in the multivariate analysis.
The findings of the trial reveal that the intervention
had the greatest impact on psychosocial factors. At the
time of the 1-year follow-up, the intervention group showed
significant improvements over the control group on stress,
diet self-efficacy, and quality of life. There was no evidence
of a long term effect of the intervention on measures of
biochemistry or anthropometry; however, there was evidence
of a potential effect of the intervention on diet adherence
at one-year follow-up. The intervention group did show
significant improvements on weight, waist circumference,
diet adherence, fitness, and cholesterol at EOP; however
these improvements were not sustained at one-year follow-
up, suggesting that the women did not develop the skills
to self-manage their health in the postintervention period.
Baseline fitness levels, lower depression, and family support
were associated with health improvements.
The findings of the qualitative analysis concur with
the quantitative trial outcomes. While the impact of the
intervention on objective health measures is equivocal, for
many women who completed the intervention, it had a
meaningful and positive impact on their psychosocial health.
Simply making the decision to partake in the intervention
was empowering to the women as this represented a decision
to prioritise their own health needs alongside the needs of
their families and provided them with a license to take time
away from the family for their own social and health needs.
Support from a partner was critical to the women’s ability to
take time away from the family to partake in health enhancing
activity outside of the home. For others though, particularly
those with less social support, group based interventions are
not the panacea for their long term healthmanagement needs
and many could not sustain changes in lifestyle after the
intervention ended; for these women the long term benefits
were minimal.
These findings are supported in the literature, for exam-
ple, other evaluations of behavioural intervention to enhance
weight loss in postpartum women [27]; Kim et al. 2012
[28, 29] also report limited or no significant differences in
postpartum weight loss, diet adherence, or physical activity
as a result of lifestyle intervention. In each case, low levels
of participation are identified as an important limiting factor.
Studies investigating barriers and facilitators to participation
in lifestyle change also identify a lack of assistance with
childcare and insufficient time as the most common barriers
to physical activity in postpartumwomen. Facilitators include
high social support and high self-efficacy and access to
childcare [30–32].
Thus, women in the early postpartum period face multi-
ple barriers to participation in group based lifestyle interven-
tion. Optimal approaches for preventative measures for this
populationmust first and foremost tackle the issue of barriers
to attendance and participation faced by this population.
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Evidence from this and other trials suggests that home-based
interventions via mail, telephone, or internet/email may be
more feasible and successful in this population.
In addition to the delivery mechanism, program content
must also be appropriate for the population; the evidence
from this study highlights two principles upon which future
interventions should be based: (i) Women with persistent
glucose dysfunction following GDM have an inadequate
understanding of their health risks, and education on the
health risks associatedwith prediabetes should be included in
any intervention with this population. (ii) Strategies that pro-
mote self-directed behaviour change must be incorporated
into programme design. The challenge facing researchers
will be to develop internet based intervention programmes
that fulfill these requirements; such programs should be
developed and tested.
5. Conclusions
For some women group or community based lifestyle inter-
vention programmes can have life affirming effects and
lead to positive outcomes. For others though, particularly
those with less social support, group based interventions
are not the panacea for their long term health management
needs. It is pertinent now to investigate whether home based
interventions that are administered via mail, telephone, or
internet/email may be more feasible and successful in this
population. Such programmes should be based on an under-
standing of the role of psychosocial factors in facilitating
or ameliorating the effectiveness of lifestyle intervention,
and programmes should be tailored to population and aim
to develop the skills for health self-management in this
population.
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